Enlivex Ltd. (ENLV) vs OSR Health, Inc. (OSRH)

Enlivex Ltd. and OSR Health, Inc. are both Biotechnology companies. Enlivex Ltd. and OSR Health, Inc. are of similar size ($4.5M and $4.1M). OSR Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Enlivex Ltd. has the higher net margin (0.00% vs −1,093.4%) and the higher return on invested capital (−5.85% vs −8.19%). Across the 14 metrics below, Enlivex Ltd. leads on 11 and OSR Health, Inc. on 3.

Valuation

Metric ENLV OSRH Biotechnology median
P/E 0.00 n/m 8.50
P/S n/m 4.00 9.71
P/B 0.00 0.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 240.66 n/m 0.64
EV/Sales n/m 6.17 9.21
Earnings yield 248,526.43% (168.18%) (33.15%)
Free cash flow yield (301.79%) (105.52%) (25.50%)

Profitability

Metric ENLV OSRH Biotechnology median
Gross margin 0.00% 35.29% 65.16%
Operating margin 0.00% (933.72%) 0.00%
Net margin 0.00% (1,093.41%) 0.00%
Free cash flow margin 0.00% (398.26%) 0.00%
Return on equity 159.77% (14.98%) (56.36%)
Return on assets 127.16% (11.24%) (48.04%)
Return on invested capital (5.85%) (8.19%) 0.00%

Growth

Metric ENLV OSRH Biotechnology median
Revenue growth (TTM) — (50.24%) 6.02%
EPS growth (last fiscal year) 3,590.26% 71.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENLV OSRH Biotechnology median
Debt to equity 0.00 0.04 0.00
Current ratio 119.39 0.18 4.72
Net debt to EBITDA 118.29 (0.29) 0.96

Dividend

Metric ENLV OSRH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENLV OSRH Biotechnology median
Market cap 4.46m 4.09m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack